These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 19637949

  • 1. Overcoming drug resistance in patients with metastatic breast cancer.
    Wong ST, Goodin S.
    Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.
    Coley HM.
    Cancer Treat Rev; 2008 Jun; 34(4):378-90. PubMed ID: 18367336
    [Abstract] [Full Text] [Related]

  • 3. Molecular mechanisms of drug resistance.
    Longley DB, Johnston PG.
    J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
    [Abstract] [Full Text] [Related]

  • 4. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
    Gligorov J, Lotz JP.
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():53-66. PubMed ID: 19101794
    [Abstract] [Full Text] [Related]

  • 5. The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategies.
    Fojo T, Coley HM.
    Clin Breast Cancer; 2007 Oct; 7(10):749-56. PubMed ID: 18021475
    [Abstract] [Full Text] [Related]

  • 6. Target-based therapies in breast cancer: current status and future perspectives.
    Normanno N, Morabito A, De Luca A, Piccirillo MC, Gallo M, Maiello MR, Perrone F.
    Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
    [Abstract] [Full Text] [Related]

  • 7. Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?
    Bedard PL, Freedman OC, Howell A, Clemons M.
    Breast Cancer Res Treat; 2008 Apr; 108(3):307-17. PubMed ID: 18351454
    [Abstract] [Full Text] [Related]

  • 8. Anthracycline resistance: the problem and its current definition.
    Gianni L.
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-11-S10-17. PubMed ID: 9275001
    [Abstract] [Full Text] [Related]

  • 9. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
    Moreno-Aspitia A, Perez EA.
    Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
    [Abstract] [Full Text] [Related]

  • 10. Overview of tumor cell chemoresistance mechanisms.
    Gatti L, Zunino F.
    Methods Mol Med; 2005 Aug; 111():127-48. PubMed ID: 15911977
    [Abstract] [Full Text] [Related]

  • 11. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.
    Cell Biochem Biophys; 2009 Aug; 55(2):95-105. PubMed ID: 19593673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
    Labbozzetta M, Notarbartolo M, Poma P, Maurici A, Inguglia L, Marchetti P, Rizzi M, Baruchello R, Simoni D, D'Alessandro N.
    Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluoropyrimidine resistance in colon cancer.
    Gorlick R, Banerjee D.
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):409-16. PubMed ID: 12647984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.